These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 15585078)

  • 1. Proteomic analysis of human breast cancer tissue with laser-capture microdissection and reverse-phase protein microarrays.
    Cowherd SM; Espina VA; Petricoin EF; Liotta LA
    Clin Breast Cancer; 2004 Dec; 5(5):385-92. PubMed ID: 15585078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of proteomic analysis to monitor responses to biological therapies.
    Espina V; Dettloff KA; Cowherd S; Petricoin EF; Liotta LA
    Expert Opin Biol Ther; 2004 Jan; 4(1):83-93. PubMed ID: 14680471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laser capture microdissection and advanced molecular analysis of human breast cancer.
    Fuller AP; Palmer-Toy D; Erlander MG; Sgroi DC
    J Mammary Gland Biol Neoplasia; 2003 Jul; 8(3):335-45. PubMed ID: 14973377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein pathway activation mapping of brain metastasis from lung and breast cancers reveals organ type specific drug target activation.
    Improta G; Zupa A; Fillmore H; Deng J; Aieta M; Musto P; Liotta LA; Broaddus W; Petricoin EF; Wulfkuhle JD
    J Proteome Res; 2011 Jul; 10(7):3089-97. PubMed ID: 21574647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of laser microdissection and reverse-phase protein microarrays to the molecular profiling of cancer signal pathway networks in the tissue microenvironment.
    Espina V; Wulfkuhle J; Liotta LA
    Clin Lab Med; 2009 Mar; 29(1):1-13. PubMed ID: 19389547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining laser capture microdissection and proteomics: methodologies and clinical applications.
    Xu BJ
    Proteomics Clin Appl; 2010 Feb; 4(2):116-23. PubMed ID: 21137037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In situ proteomic analysis of human breast cancer epithelial cells using laser capture microdissection: annotation by protein set enrichment analysis and gene ontology.
    Cha S; Imielinski MB; Rejtar T; Richardson EA; Thakur D; Sgroi DC; Karger BL
    Mol Cell Proteomics; 2010 Nov; 9(11):2529-44. PubMed ID: 20739354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combining laser capture microdissection and proteomics techniques.
    Mustafa D; Kros JM; Luider T
    Methods Mol Biol; 2008; 428():159-78. PubMed ID: 18287773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of laser capture microdissected cells by 2-dimensional gel electrophoresis.
    Zhang D; Koay ES
    Methods Mol Biol; 2008; 428():77-91. PubMed ID: 18287769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic analysis in human breast cancer: identification of a characteristic protein expression profile of malignant breast epithelium.
    Hudelist G; Singer CF; Pischinger KI; Kaserer K; Manavi M; Kubista E; Czerwenka KF
    Proteomics; 2006 Mar; 6(6):1989-2002. PubMed ID: 16470630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer proteomics by laser capture microdissection, sample pooling, 54-cm IPG IEF, and differential iodine radioisotope detection.
    Neubauer H; Clare SE; Kurek R; Fehm T; Wallwiener D; Sotlar K; Nordheim A; Wozny W; Schwall GP; Poznanović S; Sastri C; Hunzinger C; Stegmann W; Schrattenholz A; Cahill MA
    Electrophoresis; 2006 May; 27(9):1840-52. PubMed ID: 16645950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The advantage of laser-capture microdissection over whole tissue analysis in proteomic profiling studies.
    De Marchi T; Braakman RB; Stingl C; van Duijn MM; Smid M; Foekens JA; Luider TM; Martens JW; Umar A
    Proteomics; 2016 May; 16(10):1474-85. PubMed ID: 27030549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laser capture microdissection applications in breast cancer proteomics.
    Braakman RB; Luider TM; Martens JW; Foekens JA; Umar A
    Methods Mol Biol; 2011; 755():143-54. PubMed ID: 21761300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining the "Sibling Technologies" of Laser Capture Microdissection and Reverse Phase Protein Microarrays.
    Mueller C; Davis JB; Liotta LA
    Adv Exp Med Biol; 2019; 1188():95-111. PubMed ID: 31820385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Automated laser capture microdissection for tissue proteomics.
    Rodriguez AS; Espina BH; Espina V; Liotta LA
    Methods Mol Biol; 2008; 441():71-90. PubMed ID: 18370312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiplexed cell signaling analysis of human breast cancer applications for personalized therapy.
    Wulfkuhle JD; Speer R; Pierobon M; Laird J; Espina V; Deng J; Mammano E; Yang SX; Swain SM; Nitti D; Esserman LJ; Belluco C; Liotta LA; Petricoin EF
    J Proteome Res; 2008 Apr; 7(4):1508-17. PubMed ID: 18257519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reverse phase protein arrays: mapping the path towards personalized medicine.
    Gallagher RI; Espina V
    Mol Diagn Ther; 2014 Dec; 18(6):619-30. PubMed ID: 25358623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reverse phase protein microarrays for theranostics and patient-tailored therapy.
    Espina V; Wulfkuhle J; Calvert VS; Liotta LA; Petricoin EF
    Methods Mol Biol; 2008; 441():113-28. PubMed ID: 18370315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomics of breast cancer: enhanced expression of cytokeratin19 in human epidermal growth factor receptor type 2 positive breast tumors.
    Zhang DH; Tai LK; Wong LL; Sethi SK; Koay ES
    Proteomics; 2005 May; 5(7):1797-805. PubMed ID: 15825149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic patterns for cancer diagnosis--promise and challenges.
    Whiteley GR
    Mol Biosyst; 2006 Aug; 2(8):358-63. PubMed ID: 16880955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.